All News #Library
Others
Zhimeng`s Drug Gets Approval for Phase 2 Epilepsy Trial in China
11 Sep 2025 //
PR NEWSWIRE
Zhimeng Biopharma will report positive PIb trial results on its ZM-H1505R
14 Jun 2022 //
PRNEWSWIRE
Zhimeng Biopharma Announces Dosing in CB03 in Phase I Clinical Trial
12 May 2022 //
ASIAONE
Zhimeng Biopharma Begins Dosing of CB03 in PI Clinical Trial
11 May 2022 //
PRNEWSWIRE
Zhimeng Biopharma Beginss Dosing in First-in-Human Trial of CB06
31 Mar 2022 //
PRNEWSWIRE

Market Place
Sourcing Support